Operating Lease, Right-of-Use Asset of Petros Pharmaceuticals, Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Petros Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Petros Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $113,730, a 50% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Petros Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $113,730 -$112,529 -50% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $124,930 -$135,919 -52% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $153,741 -$140,650 -48% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $190,571 -$136,350 -42% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $226,259 -$132,213 -37% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $260,849 -$128,230 -33% 30 Sep 2023 10-Q 15 Nov 2023 2023 Q3
Q2 2023 $294,391 -$124,388 -30% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $326,921 -$120,674 -27% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $358,472 -$117,085 -25% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $389,079 -$113,618 -23% 30 Sep 2022 10-Q/A 15 Nov 2022 2022 Q3
Q2 2022 $418,779 -$110,277 -21% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $447,595 -$106,784 -19% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $475,557 -$103,978 -18% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $502,697 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $529,056 30 Jun 2021 10-Q 16 Aug 2021 2021 Q1
Q1 2021 $554,379 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $579,535 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.